Concepedia

Publication | Closed Access

GLS/IL-12-modified Mycobacterium smegmatis as a novel anti-tuberculosis immunotherapeutic vaccine.

16

Citations

0

References

2009

Year

Yong-Lin He, L Zhang, Lei Xu, Zhengjun Yi, Y Wang, N Li, Desheng Zhu
PubMed

Abstract

rMS had immunotherapeutic effects associated with a switch to the Th1 response and the antibacterial activity of GLS.